Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioScience Health Innovations (BHIC) Operating Expenses (2020 - 2025)

Historic Operating Expenses for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to $707013.0.

  • BioScience Health Innovations' Operating Expenses rose 9184.26% to $707013.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 8173.71%. This contributed to the annual value of $1.2 million for FY2024, which is 6603.84% up from last year.
  • Latest data reveals that BioScience Health Innovations reported Operating Expenses of $707013.0 as of Q3 2025, which was up 9184.26% from $616774.0 recorded in Q2 2025.
  • In the past 5 years, BioScience Health Innovations' Operating Expenses ranged from a high of $707013.0 in Q3 2025 and a low of $3209.0 during Q2 2021
  • For the 5-year period, BioScience Health Innovations' Operating Expenses averaged around $216005.1, with its median value being $181356.5 (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 1216.36% in 2021, then surged by 139217.82% in 2022.
  • Over the past 5 years, BioScience Health Innovations' Operating Expenses (Quarter) stood at $14089.0 in 2021, then skyrocketed by 105.25% to $28917.0 in 2022, then soared by 850.61% to $274887.0 in 2023, then rose by 19.7% to $329052.0 in 2024, then soared by 114.86% to $707013.0 in 2025.
  • Its Operating Expenses was $707013.0 in Q3 2025, compared to $616774.0 in Q2 2025 and $469347.0 in Q1 2025.